Skip to main content
The Journal of International Medical Research logoLink to The Journal of International Medical Research
. 2022 Nov 23;50(11):03000605221133988. doi: 10.1177/03000605221133988

Lamotrigine induced priapism in children: case analysis and literature review

Jie Ge 1, Shan-Shan Cao 1, Xiao-Yu Cao 2, Meng Tang 1, Fei Mu 1, Yi Qiao 1, Yue Guan 1, Jing-Wen Wang 1,
PMCID: PMC9703579  PMID: 36418928

Abstract

Lamotrigine is an antiepileptic drug that can be used to control many types of seizures as a single-agent or an add-on therapy in patients over 2 years of age. In addition to common adverse reactions, this current case report describes a paediatric male patient with a rare side-effect of persistent penile erectile due to lamotrigine. Previous studies have shown that it can improve sexual function in adult male patients. This patient suffered from refractory epilepsy and pneumonia. He had taken a variety of antiepileptic drugs for a long time and developed priapism after the dosage of lamotrigine had been increased. The priapism improved after drug withdrawal and sedation. Further research is needed to elucidate the mechanism of this rare side-effect.

Keywords: Lamotrigine, priapism, children, case report

Introduction

Lamotrigine is a broad-spectrum antiepileptic drug (AED) that is effective in controlling many types of seizures except severe myoclonic epilepsy in infancy.1 It can improve cognitive function and learning ability.2 It is commonly used as a single-agent or as an add-on therapy in patients over 2 years old.3,4 Common side-effects of lamotrigine include rash, Stevens–Johnson syndrome, blurred vision, diplopia and dizziness.5 There have been five case reports of hypersexuality associated with lamotrigine in adult men.6,7 This current case report describes priapism in a paediatric patient induced by lamotrigine.

Case report

In April 2021, an 11-year-old male patient presented to the Department of Pharmacy, The First Affiliated Hospital of Air Force Medical University, Xian, Shaanxi Province, China with cough and fever. The patient was diagnosed with epilepsy 3 years previously and then his motor and language function regressed for 1 year. Hypoxic–ischaemic encephalopathy was diagnosed after birth and suspected mucopolysaccharidosis (MPS) when he was 5 years old. There were no typical symptoms of MPS during this current hospitalization. The previous medical records could not be provided by the guardian and the previous treatment was not clear. There was insufficient evidence to diagnose MPS, so genetic testing was recommended. Recurrent respiratory infections that lasted for 6 months were frequent. Epilepsy was diagnosed when the patient was 8 years of age. The patient presented with different types of symptoms during his epileptic seizures: loss of consciousness, binocular gaze, head-nodding and hand tremor. Sometimes a state of continuous seizures lasted up to 20 min. Currently, the patient cannot speak or walk alone.

Prior to the current hospital admission, the patient had received long-term therapy for refractory epilepsy with 0.5 g levetiracetam oral twice a day, 100 mg lamotrigine oral twice a day, 50 mg zonisamide oral twice a day, 50 mg topiramate oral twice a day and 0.5 mg clonazepam oral twice a day, but the convulsive seizures still occurred 3–4 times a day. These seizures took a variety of forms comprising binocular gaze and limb stiffness, lasted a few seconds or minutes, and the electroencephalograph was abnormal, so he was transferred to the paediatric intensive care unit for further treatment.

The child suffered from refractory epilepsy (suspected Lennox-Gastuat Syndrome) and pneumonia. He was administered AEDs and anti-infective agents (cefatriaxone and azithromycin as described below) at the same time. He was experiencing at least 3–4 convulsive seizures per day, so his lamotrigine dose was increased 150 mg oral twice a day for 4 days and 2 mg perampanel oral once a day for 4 days was added on day 5 of hospitalization. He also received 1.7 g cefatriaxone intravenous drip once a day for 9 days and 0.3 g azithromycin oral once a day for 2 days. Four days later, the patient developed a persistent penile erection. The published literature on adverse reactions to lamotrigine and perampanel were reviewed. It was confirmed that the priapism could be attributable to lamotrigine according to the Naranjo Scale. As a consequence, lamotrigine was discontinued but other treatments remained unchanged. The penile erection lasted for approximately 20 h.

The maximum recommended dose of lamotrigine is 200 mg in children aged 2–11 years when using it with other drugs that do not significantly inhibit or induce its glucuronidation.8 The dosage of this child was increased to 300 mg lamotrigine per day. When priapism occurred, the child was intermittently given drug withdrawal, treated with midazolam for sedation and the symptoms were relieved. The determination of drug concentration would have been useful, but unfortunately it was not undertaken. For ongoing long-term treatment, 100 mg lamotrigine once a day was added back to the AED regimen and there was no recurrence of priapism at 1 month follow-up.

The case report received approval for publication from the Ethics Committee of The First Affiliated Hospital of Air Force Medical University, Xian, Shaanxi Province, China (no. KY20222245). Verbal consent was obtained from the patient’s guardian for publication of this case report. All patient details have been de-identified. The reporting of this study conformed to CARE guidelines.9

Discussion

As part of a review of the adverse effects of lamotrigine, the PubMed® and EMBASE databases were searched using the following words: sexual dysfunction, decreased libido, lack of libido, erectile dysfunction, impotence, ejaculatory inhibition, anejaculation, delayed orgasm, anorgasmia, priapism, premature ejaculation, retrograde ejaculatory and hypersexuality. Evidence suggests that lamotrigine improved sexual function in adult male patients.6,7

It is generally believed that sexual dysfunction is very common in patients with epilepsy. The aetiological basis of sexual dysfunction is likely to be multifactorial such as the epilepsy itself, the AEDs and psychosocial factors. A review published in 2017 focused on the role of AEDs in sexual function.10 Most of the AEDs cause sexual dysfunction, but a few can increase libido, which might be associated with their effects on reproductive hormones (testosterone/oestradiol).11,12 This current child was being treated with six AEDs, none of which was expected to lead to a high incidence of sexual dysfunction, such as might be observed with carbamazepine, phenytoin, phenobarbital and sodium valproate.10 There have been some reports about the effects on sexual function in both men and women of the AEDs used in this current patient. For example, levetiracetam has no effect on hormones and its effect on sexual function remains controversial, but it may improve sexual function or decreased libido in men.10 Zonisamide and topiramate were reported to cause erectile dysfunction in case reports of male patients.10 Clonazepam is used as an add-on therapy for adults and children with refractory focal onset or generalized onset epileptic seizures.13 Its common adverse events included sexual dysfunction.14 Perampanel has been approved as an effective and safe drug for the treatment of adults and adolescents with drug-resistant epilepsy and there have been no adverse reactions related to sexual function based on post-marketing surveillance.15,16 Lamotrigine has been primarily reported to improve sexual function, particularly in women.17,18 Little information exists on its effects on sexual function in men. Table 1 presents the key information from three reports that describe the effects of lamotrigine on sexual function in six adult male patients.6,7,19

Table 1.

Major characteristics of case reports describing the effects of lamotrigine on sexual function in seven male patients.

Author Dosage of lamotrigine Diseases Age, years Combination drug therapy Effect on sexual function
Current case 150 mg twice a day (300 mg daily) Epilepsy, pneumonia 11 Levetiracetam, zonisamide, topiramate, clonazepam, perampanel, cefatriaxone, azithromycin Persistent penile erection for 20 h
Husain et al. 20006 500 mg daily Epilepsy 48 Phenobarbital, gabapentin, clonazepam Improved potency and orgasm twice a week
800 mg daily Epilepsy 48 Phenytoin Sexually active 3–4 times a month
Complex partial seizures 62 Phenytoin, phenobarbital, carbamazepine, valproate Impotence gradually resolved
Grabowska-Grzyb et al. 20067 50 mg twice a day (100 mg daily) Temporal lobe epilepsy 55 Carbamazepine Obsessive thoughts about sexual activity, several erections a day, masturbated several times a day
100 mg daily Frontal lobe epilepsy, interictal depression (social disability, permanent anxiety, insomnia) 50 Oxcarbazepine Sex drive improved, several erections per day, improved sex life
Kaufman et al. 201719 300 mg daily Depression, panic disorder, post-traumatic stress disorder, epilepsy, hypertension, gastro-oesophageal reflux disease, hydrocephalus 56 Escitalopram, mirtazapine, alprazolam, enalapril, lansoprazole Became libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia when off lamotrigine for 48 h

A previous report described three men treated with lamotrigine for epilepsy.6 A 48-year-old patient that was taking phenobarbital and gabapentin complained of decreased potency and anorgasmia; after the dosage of gabapentin was reduced and lamotrigine was added, anorgasmia improved.6 The second 48-year-old patient complained of impotence while applying different treatment strategies with taking phenytoin and carbamazepine or phenobarbital, valproate and gabapentin.6 After gabapentin was replaced with lamotrigine, impotence improved.6 The third 62-year-old patient was treated with five AEDs and complained of long-standing impotence.6 This was gradually resolved within a few months after lamotrigine was substituted for gabapentin.6 A second report described two patients with epilepsy treated with lamotrigine.7 A 55-year-old patient that had not had sexual intercourse for 7 years started having obsessive thoughts about sexual activity and experienced several erections a day while taking lamotrigine.7 After masturbating several times a day, he found these symptoms hard to accept and lamotrigine was discontinued.7 Another 50-year-old patient whose frequency of sexual intercourse had been once every 6 months found an improvement in his sex drive and experienced several erections per day after receiving lamotrigine, so finding this pleasant he continued to use lamotrigine to improve his sex life.7 The sixth patient was a 56-year-old man that reported that he became libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia when he came off lamotrigine for 48 h.19 As this appears to be the opposite effect, it is thought that it might have been a withdrawal reaction.19 All of above cases occurred in adult males, whereas this current case report presents an adolescent boy that developed a persistent penile erection. It appears to be a short-term adverse reaction that might have negative consequences in some patients. Researchers found that priapism in children for more than 24 h may cause permanent injury, so it deserves more attention.20

The current case was taking six AEDs and antibiotics at the same time. A previous report summarized the interactions between AEDs and between AEDs and other drugs.21 There have been no reports of ceftriaxone interacting with AEDs. Macrolides such as erythromycin might interact with AEDs, especially carbamazepine.21 There were no interactions found with azithromycin.21 Topiramate (≥200 mg/day) and perampanel (≥8 mg/day) have weaker enzyme-inducing properties.21 Topiramate in combination with zonisamide might increase the risk of kidney stones and metabolic acidosis, as well as impaired cognition.22,23 The dosage of drugs in this current case was below the interaction limit and the child had no other symptoms. A study in children with intractable epilepsy found the plasma concentration of clonazepam was reduced when lamotrigine was introduced.24 The limitation of this current case report was the absence of routine therapeutic drug monitoring of these AEDs, especially lamotrigine. Levetiracetam does not affect plasma concentrations of other AEDs in children with epilepsy.25 The increase in the dose of lamotrigine in the current patient was rapid (increased to 300 mg lamotrigine per day), which might have had an impact on priapism.

Research shows that priapism, a prolonged penile erection lasting >4 h, is a rare condition in children.20 Ischaemic priapism is the commonest type and is typically painful, so an assessment should be undertaken as a matter of urgency to avoid permanent cavernosal structural damage.20 Non-ischaemic priapism may be treated less urgently.20 Sickle cell disease (65%) is the commonest cause of priapism in children, with drugs accounting for only 5%.20 Drugs known to be involved include phosphodiesterase-5 inhibitors, hormones, anti-psychotics, anti-depressants, anti-hypertensives, erythropoietin, anaesthetics, alcohol, cocaine and marijuana.20 This current child had an abnormal erection of the penis but did not complain of pain. No other complications occurred and sedation was effective in the current case. The discomfort disappeared when lamotrigine was stopped and midazolam was injected. There was no recurrence during follow-up. This adverse reaction induced by lamotrigine has not been reported before in children.

In conclusion, this current case report described an adolescent male patient with a persistent penile erection caused by lamotrigine after an increase in dose. In contrast to previous reports of improved sexual function in adult males, this is the first report in a child. More research is required to investigate the concentration of lamotrigine and testosterone levels required to further explain this phenomenon.

Supplemental Material

sj-pdf-1-imr-10.1177_03000605221133988 - Supplemental material for Lamotrigine induced priapism in children: case analysis and literature review

Supplemental material, sj-pdf-1-imr-10.1177_03000605221133988 for Lamotrigine induced priapism in children: case analysis and literature review by Jie Ge, Shan-Shan Cao, Xiao-Yu Cao, Meng Tang, Fei Mu, Yi Qiao, Yue Guan and Jing-Wen Wang in Journal of International Medical Research

Acknowledgement

We thank all authors for contributing to this article.

Footnotes

Author contributions: J.G. wrote the manuscript and provided data for Table 1. S.S.C. and X.Y.C. conducted the patient review. M.T. and F.M. supervised the work. Y.Q., Y.G. and J.W.W. reviewed the final manuscript.

The authors declare that there are no conflicts of interest.

Funding: This research received no specific grant from funding agency in the public, commercial, or not-for-profit sectors.

ORCID iD

Jie Ge https://orcid.org/0000-0003-4559-4677

References

  • 1.Gatti G, Bonomi I, Jannuzzi G, et al. The new antiepileptic drugs: pharmacological and clinical aspects. Curr Pharm Des 2000; 6: 839–860. [DOI] [PubMed] [Google Scholar]
  • 2.Lagae L. . Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy. Seizure 2006; 15: 235–241. [DOI] [PubMed] [Google Scholar]
  • 3.Kwan P. and Brodie MJ. Combination therapy in epilepsy: when and what to use. Drugs 2006; 66: 1817–1829. [DOI] [PubMed] [Google Scholar]
  • 4.Biton V, Sackellares JC, Vuong A, et al . Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005; 65: 1737–1743. [DOI] [PubMed] [Google Scholar]
  • 5.Pomeroy SJ, Ndikumana R, Cavanagh JP. Lamotrigine induced lymphadenopathy: Case report and literature review. Int J Pediatr Otorhinolaryngol 2017; 98: 82–84. [DOI] [PubMed] [Google Scholar]
  • 6.Husain AM, Carwile ST, Miller PP, et al. Improved sexual function in three men taking lamotrigine for epilepsy. South Med J 2000; 93: 335–336. [PubMed] [Google Scholar]
  • 7.Grabowska-Grzyb A, Nagańska E, Wolańczyk T. Hypersexuality in two patients with epilepsy treated with lamotrigine. Epilepsy Behav 2006; 8: 663–665. [DOI] [PubMed] [Google Scholar]
  • 8.Han SA, Yang EJ, Song MK, et al . Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients. Korean J Pediatr 2017; 60:189–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gagnier JJ, Kienle G, Altman DG, et al. ; The CARE guidelines: consensus-based clinical case reporting guideline development. Headache 2013; 53: 1541–1547. [DOI] [PubMed] [Google Scholar]
  • 10.Yogarajah M, Mula M. Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic Drugs. Curr Pharm Des 2017; 23: 5649–5661. [DOI] [PubMed] [Google Scholar]
  • 11.Rathore C, Henning OJ, Luef G, et al. Sexual dysfunction in people with epilepsy. Epilepsy Behav 2019; 100: 106495. [DOI] [PubMed] [Google Scholar]
  • 12.Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005; 65: 1016–1020. [DOI] [PubMed] [Google Scholar]
  • 13.Song L, Liu F, Liu Y, et al. Clonazepam add-on therapy for refractory epilepsy in adults and children. Cochrane Database Syst Rev 2018; 5: CD012253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nardi AE, Valença AM, Freire RC, et al. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Braz J Med Biol Res 2011; 44: 366–373. [DOI] [PubMed] [Google Scholar]
  • 15.Chang FM, Fan PC, Weng WC, et al. The efficacy of perampanel in young children with drug-resistant epilepsy. Seizure 2020; 75: 82–86. [DOI] [PubMed] [Google Scholar]
  • 16.Mahajan SS, Prakash A, Sarma P, et al. Efficacy, tolerability and safety of perampanel in population with pharmacoresistant focal seizures: A systematic review and meta-analysis. Epilepsy Res 2022; 182: 106895. [DOI] [PubMed] [Google Scholar]
  • 17.Svalheim S, Taubøll E, Luef G, et al. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. Epilepsy Behav 2009; 16: 281–287. [DOI] [PubMed] [Google Scholar]
  • 18.Gil-Nagel A, López-Muñz F, Serratosa JM, et al. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 2006; 15: 142–149. [DOI] [PubMed] [Google Scholar]
  • 19.Kaufman KR, Coluccio M, Sivaraaman K, et al. Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review. B J Psych Open 2017; 3: 249–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Donaldson JF, Rees RW, Steinbrecher HA. Priapism in children: a comprehensive review and clinical guideline. J Pediatr Urol 2014; 10: 11–24. [DOI] [PubMed] [Google Scholar]
  • 21.Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord 2014; 16: 409–431. [DOI] [PubMed] [Google Scholar]
  • 22.Jion YI, Raff A, Grosberg BM, et al . The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension. Headache 2015; 55: 161–166. [DOI] [PubMed] [Google Scholar]
  • 23.Quon RJ, Mazanec MT, Schmidt SS, et al . Antiepileptic drug effects on subjective and objective cognition. Epilepsy Behav 2020; 104:106906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Eriksson AS, Hoppu K, Nergårdh A, et al. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996; 37: 769–773. [DOI] [PubMed] [Google Scholar]
  • 25.Otoul C, De Smedt H, Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 2007; 48: 2111–2115. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-pdf-1-imr-10.1177_03000605221133988 - Supplemental material for Lamotrigine induced priapism in children: case analysis and literature review

Supplemental material, sj-pdf-1-imr-10.1177_03000605221133988 for Lamotrigine induced priapism in children: case analysis and literature review by Jie Ge, Shan-Shan Cao, Xiao-Yu Cao, Meng Tang, Fei Mu, Yi Qiao, Yue Guan and Jing-Wen Wang in Journal of International Medical Research


Articles from The Journal of International Medical Research are provided here courtesy of SAGE Publications

RESOURCES